Microbot Medical
MBOT
79 hedge funds and large institutions have $34.3M invested in Microbot Medical in 2026 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 26 increasing their positions, 13 reducing their positions, and 11 closing their positions.
100% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 11
100% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 13
51% more capital invested
Capital invested by funds: $22.8M → $34.3M (+$11.5M)
13% more funds holding
Funds holding: 70 → 79 (+9)
4.24% more ownership
Funds ownership: 16.96% → 21.2% (+4.2%)
17% less call options, than puts
Call options by funds: $850K | Put options by funds: $1.03M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$1.07M |
| 2 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$1.07M |
| 3 |
Millennium Management
New York
|
+$911K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$830K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$686K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$717K |
| 2 |
6CM
683 Capital Management
New York
|
-$192K |
| 3 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$135K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$132K |
| 5 |
Jane Street
New York
|
-$125K |
MBOT Hedge Fund Activity: Q1 2026 in Review
79 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q1 2026, worth a combined $34.3M — up 51% from $22.8M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new MBOT positions and 11 closed out — a net gain of 11 holders — while 26 added to existing stakes and 13 trimmed.
The largest buyer was Marshall Wace, opening a new position worth an estimated $1.07M. The largest seller was Susquehanna International Group, cutting an estimated $717K.
- 79 institutional investors held Microbot Medical (MBOT) as of Q1 2026, up from 70 in Q4 2025.
- Funds reported $34.3M of Microbot Medical stock for Q1 2026, up 51% quarter-over-quarter.
- 22 funds opened new Microbot Medical positions in Q1 2026 and 11 closed out, a net change of +11 holders.
- The largest Microbot Medical buyer in Q1 2026 was Marshall Wace, an estimated $1.07M added.
- The largest Microbot Medical seller in Q1 2026 was Susquehanna International Group, an estimated $717K sold.
Based on aggregated 13F filings for Q1 2026.